Global Shingles Vaccine Research Report 2023: Market Trends and Research Activates – Shingrix Dominates the Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Shingles Vaccine Market by Product (SkyZoster, Zostavax, Shingrix), Type (Live Attenuated Vaccine, Recombinant Vaccine) – Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation – Forecast 2023-2030” report has been added to ResearchAndMarkets.com’s offering.

The Global Shingles Vaccine Market on a global scale is expected to experience substantial growth to 2030

In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

Regional revenue generation has been boosted by economic and significant infrastructure development. The analysis of patterns related to domestic production, import and export, and consumption has enabled market participants to capitalize on potential opportunities.

Furthermore, the accompanied qualitative and quantitative parameters in the report, including detailed analysis, have highlighted the market’s driving and restraining factors.

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share.

The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

• Market Penetration: Provides comprehensive information on the market offered by the key players
• Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
• Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
• Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
• Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
• Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

Market Dynamics

Drivers

• Increasing prevalence of chronic diseases
• Rising number of geriatric population
• Growing focus on immunization across the world

Restraints

• High capital necessary for vaccine development

Opportunities

• Research & development on shingles vaccines
• Emerging initiatives from companies in research and development of vaccines

Challenges

• Side effects of shingles vaccines

Market Trends

• Cumulative Impact of COVID-19
• Cumulative Impact of Russia-Ukraine Conflict
• Cumulative Impact of High Inflation
• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Regulatory Framework

Market Segmentation & Coverage:

• Based on Product, the market is studied across SkyZoster, Zostavax, and Shingrix. Shingrix is projected to witness significant market share during forecast period.
• Based on Type, the market is studied across Live Attenuated Vaccine and Recombinant Vaccine. The Recombinant Vaccine is projected to witness significant market share during forecast period.

Competitive Portfolio

• Biogenetech
• CanSino Biologics Inc.
• CSL Limited
• Emergent Biosolutions Inc.
• GeneOne Life Science
• GlaxoSmithKline PLC
• Jiangsu Recbio Technology Co., Ltd.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi-aventis Groupe
• SK Chemicals
• Vaccitech PLC

For more information about this report visit https://www.researchandmarkets.com/r/uvboij

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900